Rapamycin/metformin co‐treatment normalizes insulin sensitivity and reduces complications of metabolic syndrome in type 2 diabetic mice-Reference-Cited by-同舟云学术

Rapamycin/metformin co‐treatment normalizes insulin sensitivity and reduces complications of metabolic syndrome in type 2 diabetic mice

Author:

Reifsnyder Peter C.¹^ORCID,Flurkey Kevin¹,Doty Rosalinda¹,Calcutt Nigel A.²,Koza Robert A.³⁴⁵,Harrison David E.¹^ORCID

Affiliation:

1. The Jackson Laboratory Bar Harbor Maine USA

2. Department of Pathology University of California San Diego La Jolla California USA

3. Center for Molecular Medicine Maine Medical Center Research Institute Scarborough Maine USA

4. Graduate School of Biomedical Sciences and Engineering University of Maine Orono Maine USA

5. Pennington Biomedical Research Center Baton Rouge Louisiana USA

Funder

National Institute on Aging

National Institutes of Health

Publisher

Wiley

Subject

Cell Biology,Aging

Link

Reference74 articles.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

3. Metabolic syndrome and neuroprotection;SCT Proceedings in Interdisciplinary Insights and Innovations;2024-06-12